Pregnant women with COVID-19 are more susceptible to pre-eclampsia
A review of the scientific literature published by Brazilian researchers shows that pregnant women infected by the novel coronavirus run […]
» Read moreHome »
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the […] In a recent study, Indian researchers from the Department of Biochemistry, University of Delhi, reviewed a possible vital coalition of […] It is widely assumed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted from a zoonotic transition from bats […] The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has proved to be […] The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […] The molecular details of how SARS-CoV-2 enters cells and infects them are still not clear. Researchers at Uppsala University have […] The pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) involves a highly aggressive inflammatory response that primarily damages the […] Blood pressure medication according to the study, no risk factor for severe COVID-19-gradients Many patients are confused by current speculation: […]
Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations
Forkhead box O's potential therapeutic use in the treatment of COVID-19
Single mutation to bat virus spike protein allows cell entry using human ACE2
ACE2 homology in laboratory and wild animals
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
Researchers find new clues to how SARS-CoV-2 infects cells
Coronavirus: B Cells and T Cells
COVID-19: Not a poorer prognosis due to blood pressure drugs – Naturopathy, naturopathic specialist portal
